Asthma Clinical Trials in Colorado

20 recruiting studies across 2 cities

Browse by City

All Trials in Colorado

Phase

Trial	Phase	Sponsor	Dist.
Reducing Asthma Attacks in Disadvantaged School Children With Asthma	N/A	University of Colorado, Denver	<1 mi
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma	Phase 2	Eli Lilly and Company	<1 mi
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma	Phase 3	GlaxoSmithKline	<1 mi
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma	Phase 2	Pfizer	<1 mi
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations	Phase 3	Teva Branded Pharmaceutical Products R&D LLC	<1 mi
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults	Phase 2	Enveda Therapeutics	<1 mi
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma	Phase 3	AstraZeneca	<1 mi
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment	Phase 3	AstraZeneca	<1 mi
Study to Improve Deployment Related Asthma by Using L-Citrulline Supplementation	Phase 2	University of Colorado, Denver	<1 mi
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma	Phase 4	Regeneron Pharmaceuticals	<1 mi
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma.	Phase 2	Sanofi	5 mi
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma	Phase 3	Teva Branded Pharmaceutical Products R&D, Inc.	5 mi
A Study to Evaluate Solriktug in Adult Participants With Asthma	Phase 2	Uniquity One (UNI)	6 mi
Individualizing Treatment for Asthma in Primary Care (Full Study)	Phase 4	DARTNet Institute	8 mi
Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics	N/A	University of Colorado, Denver	8 mi
Protocol CAUSE-03 / CHEETAH	—	National Institute of Allergy and Infectious Diseases (NIAID)	8 mi
Registry of Asthma Characterization and Recruitment 3 (RACR3)	—	National Institute of Allergy and Infectious Diseases (NIAID)	8 mi
Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma	Phase 2	University of Colorado, Denver	8 mi
Navigating Together for Equitable Asthma Management for Children in Families Who Communicate in Language Other Than English	N/A	University of Colorado, Denver	8 mi
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)	—	Duke University	8 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.